Innovative Therapies Inc (ITI) Announces New Executive Management Team of the Wound Care Therapy Division and New User Friendly

Innovative Therapies Inc (ITI) Announces New Executive Management Team of the
          Wound Care Therapy Division and New User Friendly Website

"Leading with Innovation, Innovative Therapies' main goal is to ensure
patients requiring negative pressure wound therapy (NPWT) receive better care"

PR Newswire

GAITHERSBURG, Md., Feb. 26, 2013

GAITHERSBURG, Md., Feb. 26,2013 /PRNewswire/ -- Innovative Therapies Inc
(ITI) announced today it has launched a new website ( and
appointed a new executive management team for the negative pressure wound
therapy division.

Richard Vogel, CEO, founded ITI in 2006 and has served as ITI's full-time
President and CEO since 2008. Richard has held CEO/President/COO and General
Manager positions at several medical device, pharmaceutical, and biotech
companies such as Kinetic Concepts, Inc. and American Cyanamid Company.

Dave Tumey, Chief Technology Officer (CTO), has 24 years experience in the
field of biomedical R&D,including Director of V.A.C. R&D at Kinetic Concepts
Inc. (KCI). Dave hasfifty-four issuedpatents with many others pending,and
has abackground inelectricalengineering.

Matt Dambeck, Chief Operating Officer (COO), recently joined Innovative
Therapies from Stryker and is responsible for operations, sales and clinical
service delivery. He has 10 years' experience in the medical device industry,
most recently as an Area Director of Sales.

Sandra Berriman, Ph.D., Vice President of Medical Affairs, has over
18yearsexperiencein advancing pharmaceutical and medical
deviceentitiesinto the healthcare marketplace. While at Pfizer, her clinical
teamdevelopedandlaunchedToviaz, as well as scientificallysupported Detrol
LA and Viagra.

Christine Grogan, Vice President of Marketing, has over 20 years ofhealthcare
experience in medical and consumermarketing,sales, sales training and
management at Allergan, Pfizer, and Parke Davis. She has heldkey
leadershiproles as Director of Botox and Senior Director of Breast Implants
at Allergan. Christine stated that this new website would be invaluable to
health care providers in the wound care space as well as for patients looking
for more information about the benefits of negative pressure wound therapy.

Richard Vogel statedthat"This newly appointed executive teamhas
vastexperience in launchingblockbustermedicalproducts,and is committed to
ensuring that patients in the wound care spaceget the best therapy that this
field can offer."

SOURCE Innovative Therapies Inc

Contact: Christine Grogan, +1-917-617-0141,
Press spacebar to pause and continue. Press esc to stop.